Euthyrox (levothyroxine) is Provell Pharmaceuticals’ FDA-approved treatment for hypothyroidism and pituitary thyrotropin in thyroid cancer patients. Mark Cuban’s drug company also sells brand-name medications from Pfizer, Bayer and Johnson & Johnson.
The 20 other branded therapies Cost Plus Drugs offers:
- Advair Diskus (fluticasone/salmeterol)
- Brenzavvy (bexagliflozin)
- CaroSpir (spironolactone)
- Climara (estradiol)
- Clomid (clomiphene citrate)
- Dexamethasone Intensol (dexamethasone)
- Duavee (conjugated estrogens/bazedoxifene)
- Estring (estradiol)
- GaviLyte-C (PEG 3350-KCl-Na bicarb-NaCl-Na sulfate)
- Invokamet (canagliflozin-metformin HCl)
- Invokamet XR (canagliflozin-metformin HCl)
- Invokana (canagliflozin)
- Nitro-Bid (nitroglycerin)
- Premarin (conjugated estrogens)
- Premphase (conjugated estrogens/medroxyprogesterone)
- Prempro (conjugated estrogens/medroxyprogesterone)
- Promethegan (promethazine HCl)
- Tirosint (levothyroxine sodium)
- Yaz (drospirenone/ethinyl estradiol)
- Yusimry (adalimumab-aqvh)
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.